| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.005 | 1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0023 | 1 |